The detailed information for PTAB case with proceeding number IPR2024-00623 filed by Merck Sharp & Dohme LLC et al. against The Johns Hopkins University on Mar 4, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.
| Document Name | Filing Date | Category | Filing Party |
|---|---|---|---|
Alert me when new update on this case | |||
Order Conduct of the Proceeding | Jun 18, 2025 | PAPER | BOARD |
Ex. 3009 Attorney Correspondence | Jun 16, 2025 | EXHIBIT | BOARD |
Order: Canceling Oral Argument | Jun 16, 2025 | PAPER | BOARD |
Public_Patent Owners Sur-Reply | Jun 12, 2025 | PAPER | PATENT OWNER |
Public_Deposition Transcript of Paul E. Oberstein | Jun 12, 2025 | EXHIBIT | PATENT OWNER |
Public_Deposition Transcript of Sean D. Sheridan | Jun 12, 2025 | EXHIBIT | PATENT OWNER |
ORDER Setting Oral Argument 37 C.F.R. § 42.70 | Jun 3, 2025 | PAPER | BOARD |
Confidential_Patent Owners Sur-Reply | May 29, 2025 | PAPER | PATENT OWNER |
Confidential_Deposition Transcript of Paul E. Oberstein | May 29, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Deposition Transcript of Sean D. Sheridan | May 29, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal Sur-Reply and Exhibits | May 29, 2025 | PAPER | PATENT OWNER |
Petitioner's Reply [Redacted] | May 15, 2025 | PAPER | PETITIONER |
Exhibit 1137 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1150 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1151 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1244 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1245 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1269 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Exhibit 1270 [Redacted] | May 15, 2025 | EXHIBIT | PETITIONER |
Patent Owner's Request for Oral Argument | May 12, 2025 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | May 12, 2025 | PAPER | PETITIONER |
Petitioner's Current List of Exhibits | May 1, 2025 | PAPER | PETITIONER |
Exhibit 1113 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1114 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1115 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1117 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1120 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1122 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1128 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1129 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1130 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1134 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1135 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1136 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1137 [REDACTED] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1138 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1139 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1140 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1141 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1145 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1146 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1147 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1148 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1149 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1152 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1153 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1154 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1155 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1156 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1158 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1159 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1160 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1161 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1162 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1163 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1164 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1165 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1166 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1167 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1168 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1169 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1170 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1171 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1172 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1173 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1174 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1175 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1176 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1177 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1178 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1179 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1180 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1181 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1182 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1183 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1184 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1185 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1186 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1187 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1188 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1189 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1190 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1191 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1192 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1193 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1194 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1195 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1196 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1197 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1198 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1199 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1200 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1201 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1202 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1203 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1204 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1205 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1206 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1207 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1208 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1209 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1210 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1213 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1214 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1215 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1217 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1218 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1219 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1220 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1221 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1222 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1223 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1224 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1225 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1238 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1242 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1243 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1246 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1249 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1250 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1251 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1252 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1253 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1254 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1255 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1256 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1257 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1258 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1259 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1260 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1261 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1262 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1263 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1264 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1265 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1266 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1267 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1268 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1273 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1275 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1276 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1277 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1278 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1279 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1280 | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1281 | May 1, 2025 | EXHIBIT | PETITIONER |
Petitioner's Motion to Seal | May 1, 2025 | PAPER | PETITIONER |
Exhibit 1116 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1118 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1119 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1137 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1150 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1151 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1157 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1244 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1245 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1269 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1270 [Confidential] | May 1, 2025 | EXHIBIT | PETITIONER |
Petitioner's Reply [Confidential] | May 1, 2025 | PAPER | PETITIONER |
Notice of Stipulation to Modify Due Dates | Apr 10, 2025 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dung Le M.D | Apr 10, 2025 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Nils Lonberg, Ph.D. | Apr 10, 2025 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Jennifer Newberger | Apr 8, 2025 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Richard Goldberg, M.D. | Apr 8, 2025 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Brian J. Segers | Apr 8, 2025 | PAPER | PETITIONER |
Petitioner's Corrected Notice of Deposition of Brian J. Segers | Apr 8, 2025 | PAPER | PETITIONER |
Patent Owners Updated Mandatory Notice | Mar 28, 2025 | PAPER | PATENT OWNER |
Patent Owners Updated Power of Attorney | Mar 28, 2025 | PAPER | PATENT OWNER |
ORDER Conditionally Granting Patent Owner’s Motions for Pro Hac Vice Admission of Caroline (Gracie) Koonce. 37 C.F.R. § 42.10 | Mar 26, 2025 | PAPER | BOARD |
Patent Owner's Unopposed Motion for PHV Admission of Caroline Koonce | Mar 18, 2025 | PAPER | PATENT OWNER |
PHV Declaration - Caroline Koonce | Mar 18, 2025 | EXHIBIT | PATENT OWNER |
Patent Owners Updated Mandatory Notice | Jan 29, 2025 | PAPER | PATENT OWNER |
Public_Patent Owners Response | Jan 28, 2025 | PAPER | PATENT OWNER |
Public_Declaration of Brian Segers | Jan 28, 2025 | EXHIBIT | PATENT OWNER |
Petitioner's Objections to Patent Owner's Exhibits | Jan 21, 2025 | PAPER | PETITIONER |
Confidential - Protective Order Material | Jan 15, 2025 | EXHIBIT | PATENT OWNER |
Confidential - Protective Order Material | Jan 15, 2025 | EXHIBIT | PATENT OWNER |
Confidential - Protective Order Material | Jan 15, 2025 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Nils Lonberg | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
News Release_Keytruda | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bacher_Development of a Fluorescent Multiplex Assay | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Diaz_Liquid Biopsies | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Brahmer_Phase I Study | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
The Cancer Genome Atlas Network | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Mandrekar_All-Comers versus Enrichment Design | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Freidlin_Randomized Clinical Trials | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Malik_Consensus Report | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NIH_What is Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Weiss_Open Questions | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Mumphrey_Distinct Mutational Processes | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Jenkins_Antigen Presentation | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Wherry_Viral Persistence | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lotze_Lysis of Fresh and Cultured Autologous Tumor | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Briukhovetska_Interleukins in Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bod_B-Cell-Specific Checkpoint | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Wang_CD19 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Michaud_Regulatory B Cells in Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Nakhoda_Addressing Recent Failures | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Korman_The Foundations | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NIH_Immune Checkpoint Inhibitors | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Boland_Microsatellite Instability | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Branch_Immune Surveillance | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Kloor_Immune Evasion | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Zhong_Comparison of Molecular and Cellular Phenotypes | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Thomas_Advancing Translational Research | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lacombe_The Dream and Reality | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
FDA Approves Mercks KEYTRUDA (pembrolizumab) | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
irst-Study-Evaluating-DNA-Mismatch-Repair | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck-Receives-Breakthrough-Therapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
MRK-USQ_Transcript_2019-02-01-Final | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck_Financial-Results-2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck_Financial-Results-2022 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck_Financial-Results-2021 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck_Financial-Results-2020 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck_Financial-Results-2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Exhibit 14 to JHU Corrected Answer and Counterclaims | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
statistic_id973523_top-drugs-based-on-projected-2024-global-sales | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
1-22-cv-03059-100, Ltr fr JHU to Judge Aslan | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Nils Lonberg | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Connolly_Novel Mouse Models | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Sun_Immune checkpoint therapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Dobosz_Challenges of the Immunotherapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Gardner_Merck suffers bad week | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Liu_Merck's Keytruda flunks pivotal studies | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Hopkins_Merck Keeps Striking Out | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck's trial of Keytruda | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Study of Pembrolizumab | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
van der Bruggen_A gene encoding an antigen | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lawrence_Mutational heterogeneity | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Kitano_Myeloid-derived suppressor | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Snyder_Genetic basis for clinical response | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Chan_Genetic Basis for Clinical Response | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
McGranahan_Clonal neoantigens | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Hellmann_Tumor Mutational | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
FDA grants nivolumab accelerated approval | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Boyiadzis_Significance and implications | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Richard Goldberg | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bray_Global cancer statistics | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Zeineddine_Survival improvement | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Patel_The rising tide | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Sinicrope_Increasing Incidence | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Sinicrope_Lynch Syndrome | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Sargent_Defective mismatch repair | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Keung_The eighth edition American Joint Committee | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Ogunwobi_Biomarkers in Colorectal Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Kong_Prolonged surveillance | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Modulation of fluorouracil | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Dy_Long-term survivors | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Saltz_Irinotecan plus fluorouracil | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Sanoff_Five-year data | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Hurwitz_Bevacizumab plus irinotecan | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Saltz_Phase II trial | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Van Cutsem_Cetuximab and chemotherapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Van Cutsem_Open-label phase III trial | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Tabernero_Aflibercept versus placebo | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
McRee_Optimal management | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lucas_A decade of advances | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Modest_Treatment sequencing | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Grothey_Regorafenib monotherapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Mayer_Randomized trial of TAS-102 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Topalian_Immune checkpoint blockade | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Robert_Pembrolizumab versus Ipilimumab | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Reck_Pembrolizumab versus Chemotherapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Le_Mismatch repair deficiency | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Ethical Guidelines | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
The Belmont Report | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
The Cancer Letter, Vol. 43, No. 38, Oct. 13, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
The Cancer Letter, Vol. 48, No. 23, June 10, 2022 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
How Beth Carner went from six weeks | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA May 23, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA Oct. 2015 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA Aug. 2016 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA Mar. 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA May 18, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA June 2020 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Declaration of Dung Le, M.D. | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Investigator Initiated Clinical Trial Research | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
O'Neil_Safety and antitumor activity | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
FDA Grants Priority Review | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck Makes 3 Million Charitable Donation | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
ASCO 2015_Mismatch Repair Deficiency | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Video interview | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Declaration of Ms. Jennifer Newberger | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Dickersin_Report from the panel | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Moher_Clinical-trial registration | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
International Clinical Trials | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
The Food and Drug Administration Modernization Act | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Laine_Update on Trials Registration | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Food and Drug Administration Amendments Act | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
About ClinicalTrials.gov_Nat'l Library of Medicine | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
7th Revision of the Declaration of Helsinki | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
42 C.F.R. Pt. 11_2024 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
42 USC 282(j) Paragraph 21 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Protocol Registration Data | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
21 U.S.C. 331 - Prohibited acts | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
21 U.S.C. 333 - Penalties | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
De Angelis_Clinical trial registration | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Stenographic Deposition of Alfred I. Neugut, M.D., Ph.D. | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
EX1096 from '187 proceeding_IPR2024-00649 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Record History Tab | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Comparison_ClinicalTrials.gov | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 1 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 2 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 4 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 5 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 6 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 7 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 8 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 9 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
André_KEYNOTE-177 Investigators | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Henig_Could Immunotherapy Lead the Way | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Exhibit 2 KEYTRUDA claim chart | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Marques_Tumor mutational burden | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Le_Phase II Open-label study | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Nair_High Impact Journals 2024 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 3 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 10 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Email correspondence from Luis Diaz | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Breakthroughs in Immunotherapy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Guidance for Industry | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 11 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Document 12 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Email correspondence from Preston K. Ratliff | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
How Does KEYTRUDA Work | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 27, 2015 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 26, 2024 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck Private Company Profile | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Johns Hopkins University Educational Institution Profile | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Research and Faculty | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Nobel Prize Winners | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Is KEYTRUDA Right for You | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lorenzi_Epidemiology of Microsatellite Instability High | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Boland_Microsatellite Instability | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Siegel_Cancer statistics | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Immune Checkpoint Inhibitors | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
How KEYTRUDA is Given | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Accelerated Approval Letter | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
FDA Converts to Full Approval | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck KEYTRUDA August 2024 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q2 2018 Earnings Call_July 27, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q3 2018 Earnings Call_October 25, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q4 2018 Earnings Call_February 01, 2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q1 2019 Earnings Call_April 30, 2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
List of Targeted Therapy Drugs | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q2 2018 Earnings Call_July 26, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q3 2018 Earnings Call_October 25, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Q1 2019 Earnings Call_April 25, 2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 27, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 27, 2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 26, 2020 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 25, 2021 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 25, 2022 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 24, 2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2019 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2020 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2021 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2022 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer Statistics, 2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Microsatellite Instability Biomarker | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck Q2 2017 Earnings Call_July 28, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cancer-Related Direct-to-Consumer Advertising | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Cost Information and Financial Help | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Pricing Information for OPDIVO | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Pricing Information for OPDIVO_YERVOY | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol Myers Squibb_YERVOY | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Watt_Keytruda and Opdivo | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 26, 2016 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
SEC Form 10-K_February 28, 2017 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2017 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2018 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2019 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2020 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2021 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2022 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Bristol-Myers Squibb 2023 SEC Form 10-K | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck SEC Form 10-Q_March 31, 2018 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck SEC Form 10-Q_March 31, 2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck SEC Form 10-Q_June 30, 2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Merck SEC Form 10-Q_September 30, 2023 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Siegel_Cancer Statistics 2015 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Noone_SEER Cancer Statistics Review | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Canadian Cancer Society_Survival statistics for small intestine cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
American Cancer Society_Survival rates for bile duct cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Gastric Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_ Pancreatic Adenocarcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN _Hepatocellular Carcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Biliary Tract Cancers | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Small Bowel Adenocarcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Ampullary Adenocarcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Anal Carcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Prostate Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Uterine Neoplasms | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Ovarian Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Cervical Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Neuroendocrine and Adrenal Tumors | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Thyroid Carcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Breast Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Esophageal and Esophagogastric Junction Cancers | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Testicular Cancer | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
NCCN_Head and Neck Cancers | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
EXPUNGED | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
EXPUNGED | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
EXPUNGED | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Lynch In Memoriam | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Aaltonen_Replication errors | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Aarnio_Cancer risk in mutation carriers | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Chen_Small bowel adenocarcinoma | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Review Designation Policy | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Hsiehchen_Mutation burden | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
FDA grants accelerated approval | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Prescription Drug Advertising | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Jemperli U.S. Prescribing Information | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Jemperli Prices_Coupons_Copay Cards | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Support-Resources_Jemperli | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
GSK 2021 Annual Report | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
GSK 2022 Annual Report | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
GSK 2023 Annual Report | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Yearly average currency exchange rates_IRS | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Marked EX1001 Neugut Deposition | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Marked EX1005 Neugut Deposition | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Board Email regarding Motion to Seal | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Confidential_Patent Owners Response | Jan 13, 2025 | PAPER | PATENT OWNER |
Confidential_Declaration of Brian J Segers | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Deposition of Alfred I. Neugut_January 6, 2025 | Jan 13, 2025 | EXHIBIT | PATENT OWNER |
Patent Owners Motion to Seal | Jan 13, 2025 | PAPER | PATENT OWNER |
Patent Owners Updated Mandatory Notice | Jan 3, 2025 | PAPER | PATENT OWNER |
Notice of Deposition of Alfred I. Neugut | Jan 3, 2025 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Dec 26, 2024 | PAPER | PETITIONER |
Notice of Intent to Designate Frank E. Scherkenback | Dec 26, 2024 | PAPER | PATENT OWNER |
Notice of Intent to Designate Corrin N. Drakulich | Dec 26, 2024 | PAPER | PATENT OWNER |
Notice of Intent to Designate Christina D. Brown-Marshall | Dec 26, 2024 | PAPER | PATENT OWNER |
Notice of Intent to Designate Casey M. Kraning | Dec 26, 2024 | PAPER | PATENT OWNER |
Notice of Intent to Designate Madelyn S. McCormick | Dec 26, 2024 | PAPER | PATENT OWNER |
Notice of Intent to Designate Sarah E. Jack | Dec 26, 2024 | PAPER | PATENT OWNER |
Patent Owner Power of Attorney | Dec 26, 2024 | PAPER | PATENT OWNER |
Declaration of Frank E. Scherkenbach | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Declaration of Corrin N. Drakulich | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Declaration of Christina D. Brown-Marshall | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Declaration of Casey M. Kraning | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Declaration of Madelyn S. McCormick | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Declaration of Sarah E. Jack | Dec 26, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 3007 | Dec 23, 2024 | EXHIBIT | BOARD |
Notice of Stipulation to Modify Due Dates | Dec 12, 2024 | PAPER | PATENT OWNER |
Granting Petitioner’s Motions for Pro Hac Vice Admission of Jessica Stauring 37 C.F.R. § 42.10 | Dec 10, 2024 | PAPER | BOARD |
Ex. 3006 | Dec 9, 2024 | EXHIBIT | BOARD |
ORDER Conduct of the Proceeding 37 C.F.R. § 42.5 | Dec 9, 2024 | PAPER | BOARD |
Petitioner's Motion for Pro Hac Vice Admission of Jessica Stauring | Nov 25, 2024 | PAPER | PETITIONER |
Exhibit 1112 | Nov 25, 2024 | EXHIBIT | PETITIONER |
Amended Power of Attorney for Petitioner | Nov 25, 2024 | PAPER | PETITIONER |
Petitioner's Current List of Exhibits | Nov 25, 2024 | PAPER | PETITIONER |
Petitioner's Objections to Patent Owner's Exhibits | Oct 7, 2024 | PAPER | PETITIONER |
Patent Owner's Objections to Evidence | Oct 7, 2024 | PAPER | PATENT OWNER |
Institution Decision: Grant | Sep 23, 2024 | PAPER | BOARD |
Order: Scheduling Order | Sep 23, 2024 | PAPER | BOARD |
Patent Owner's Preliminary Sur-Reply | Jul 19, 2024 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Jul 12, 2024 | PAPER | PETITIONER |
Petitioner's Current List of Exhibits | Jul 12, 2024 | PAPER | PETITIONER |
Exhibit 1100 | Jul 12, 2024 | EXHIBIT | PETITIONER |
Exhibit 1101 | Jul 12, 2024 | EXHIBIT | PETITIONER |
ORDER – Request for Reply | Jul 8, 2024 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Jul 1, 2024 | PAPER | PETITIONER |
Patent Owners Preliminary Response | Jun 26, 2024 | PAPER | PATENT OWNER |
Le_ASCO Presentation | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
FDA News Release | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Kolata_Cancer Drug | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
McGinley_This is not the end | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
News Release_Merck | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_975 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_219 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_187 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_462 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_287 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Office Action_15/611,017 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Reply to Action_15/611,017 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_15/523,451 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Sidney Kimmel Comprehensive Cancer Center | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Initial Disclosure of Invalidity Contentions | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Shaywitz_The Startling History | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
IPR2024‐00240_Paper No. 1 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Claim Construction Order | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Signed IDS_17/465,101 | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Maryland_Judicial Caseload Profile | Jun 26, 2024 | EXHIBIT | PATENT OWNER |
Notice: Notice filing date accorded | Mar 26, 2024 | PAPER | BOARD |
Patent Owner's Mandatory Notice | Mar 22, 2024 | PAPER | PATENT OWNER |
Exhibit 1001 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1002 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1004 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1005 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1006 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1007 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1008 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1009 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1010 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1011 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1012 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1013 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1014 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1015 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1016 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1017 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1018 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1019 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1020 (Part 1 of 4) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1020 (Part 2 of 4) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1020 (Part 3 of 4) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1020 (Part 4 of 4) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1021 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 1 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 2 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 3 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 4 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 5 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 6 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 7 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 8 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 9 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 10 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 (Part 11 of 11) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1023 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1024 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1025 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1026 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1027 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1029 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1030 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1031 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1032 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1033 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1034 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1035 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1036 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1037 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1038 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1039 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1041 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1042 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1043 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1044 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1045 | Mar 4, 2024 | EXHIBIT | PETITIONER |
1046 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1047 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1048 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1050 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1051 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1053 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1054 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1055 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1057 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1058 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1063 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1064 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1065 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1066 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1067 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1068 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1069 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1070 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1071 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1072 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1073 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1074 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1075 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1076 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1077 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1078 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1079 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1080 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1081 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1082 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1083 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1084 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1085 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1086 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1087 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1088 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1089 (Part 1 of 2) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1089 (Part 2 of 2) | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1090 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1092 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Exhibit 1093 | Mar 4, 2024 | EXHIBIT | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 11,325,974 | Mar 4, 2024 | PAPER | PETITIONER |
Power of Attorney for Petitioner | Mar 4, 2024 | PAPER | PETITIONER |
Exhibit 1003 | Mar 4, 2024 | EXHIBIT | PETITIONER |